As a part of its long term strategy to build a global innovation-led pharmaceutical business, Mankind Pharma (BSE: 543904 | ...
The modern landscape of biopharmaceutical manufacturing is dominated by the rapid introduction of single-use technologies (SUT) and their associated components. Highly complex and sophisticated ...
Pharmaceutical research depends on reliable experiments. A small variation in temperature, stirring, dosing, or sampling can affect the final result—and may influence important decisions about process ...
Analytical testing lies at the foundation of modern science and industry. Analytical labs are the bailiffs of science, pointing to the evidence to help make critical decisions about processes and the ...
No, Isopropanol and Isopropyl Alcohol are the same compound. A variety of other terms, along with their concentration, purity and the context in which they are used, are key in determining the ...
Sterile-to-sterile (S2S) single-use connectors have become foundational technologies in modern biopharmaceutical manufacturing. As biologics, cell therapies, mRNA platforms, and highly potent drug ...
This acquisition will allow Sun Pharma to continue on its path to strengthening its formulations and to growing its presence in therapeutics that are high on demand. Innovcare Lifesciences is ...
Numerous industries rely on the science of measurement and analysis. This science is an invaluable asset in the manufacturing of pharmaceuticals and biotechnology, in the provision of healthcare ...
Latest news and Information on Pharma, Laboratory and Analytical Industry. The contents include marketing, strategy, research, drug quality, and lab equipment launches..
The ability to give quick and accurate diagnoses is of paramount importance to the specialized fields of the ever-evolving world of healthcare. One of the most state-of-the-art innovations in ...
For almost 20 years, custom medicine’s potential for success has been driven by the ability to potentially identify molecular signatures for a disease’s etiology instead of population-based markers.
The pharmaceutical, laboratory, and analytical industries are entering a defining phase where scientific rigor, technological intelligence, and regulatory expectations are converging like never before ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results